Litcius/Paper detail

Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)

Richard J. Edmondson, Rachel O’Connell, Susana Banerjee, Linda Mileshkin, Peter Sykes, Philip Beale, Ann D Fisher, Anthony Bonaventura, David Millan, Steven Nottley, Charlotte Benson, Anne Hamilton, Katrin Marie Sjoquist, Laura E. Crotty Alexander, Caroline Kelly, Karen Carty, Laura Divers, Nathan Bradshaw, Michael Friedländer

2021Gynecologic Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAnastrozoleInternal medicineClinical endpointProgression-free survivalProgressive diseaseClinical trialGynecologyOncologyGastroenterologyDiseaseChemotherapyCancerTamoxifenBreast cancerUterine Myomas and TreatmentsEndometrial and Cervical Cancer TreatmentsSarcoma Diagnosis and Treatment